1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Acne Vulgaris Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 OTC
        1.2.3 Prescription Medicine
    1.3 Market by Application
        1.3.1 Global Acne Vulgaris Drug Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Topical
        1.3.3 Oral
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Acne Vulgaris Drug Market Perspective (2017-2028)
    2.2 Acne Vulgaris Drug Growth Trends by Region
        2.2.1 Acne Vulgaris Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Acne Vulgaris Drug Historic Market Size by Region (2017-2022)
        2.2.3 Acne Vulgaris Drug Forecasted Market Size by Region (2023-2028)
    2.3 Acne Vulgaris Drug Market Dynamics
        2.3.1 Acne Vulgaris Drug Industry Trends
        2.3.2 Acne Vulgaris Drug Market Drivers
        2.3.3 Acne Vulgaris Drug Market Challenges
        2.3.4 Acne Vulgaris Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Acne Vulgaris Drug Players by Revenue
        3.1.1 Global Top Acne Vulgaris Drug Players by Revenue (2017-2022)
        3.1.2 Global Acne Vulgaris Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Acne Vulgaris Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Acne Vulgaris Drug Revenue
    3.4 Global Acne Vulgaris Drug Market Concentration Ratio
        3.4.1 Global Acne Vulgaris Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Acne Vulgaris Drug Revenue in 2021
    3.5 Acne Vulgaris Drug Key Players Head office and Area Served
    3.6 Key Players Acne Vulgaris Drug Product Solution and Service
    3.7 Date of Enter into Acne Vulgaris Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Acne Vulgaris Drug Breakdown Data by Type
    4.1 Global Acne Vulgaris Drug Historic Market Size by Type (2017-2022)
    4.2 Global Acne Vulgaris Drug Forecasted Market Size by Type (2023-2028)
5 Acne Vulgaris Drug Breakdown Data by Application
    5.1 Global Acne Vulgaris Drug Historic Market Size by Application (2017-2022)
    5.2 Global Acne Vulgaris Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Acne Vulgaris Drug Market Size (2017-2028)
    6.2 North America Acne Vulgaris Drug Market Size by Country (2017-2022)
    6.3 North America Acne Vulgaris Drug Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Acne Vulgaris Drug Market Size (2017-2028)
    7.2 Europe Acne Vulgaris Drug Market Size by Country (2017-2022)
    7.3 Europe Acne Vulgaris Drug Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Acne Vulgaris Drug Market Size (2017-2028)
    8.2 Asia-Pacific Acne Vulgaris Drug Market Size by Country (2017-2022)
    8.3 Asia-Pacific Acne Vulgaris Drug Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Acne Vulgaris Drug Market Size (2017-2028)
    9.2 Latin America Acne Vulgaris Drug Market Size by Country (2017-2022)
    9.3 Latin America Acne Vulgaris Drug Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Acne Vulgaris Drug Market Size (2017-2028)
    10.2 Middle East & Africa Acne Vulgaris Drug Market Size by Country (2017-2022)
    10.3 Middle East & Africa Acne Vulgaris Drug Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Galderma
        11.1.1 Galderma Company Detail
        11.1.2 Galderma Business Overview
        11.1.3 Galderma Acne Vulgaris Drug Introduction
        11.1.4 Galderma Revenue in Acne Vulgaris Drug Business (2017-2022)
        11.1.5 Galderma Recent Development
    11.2 Bausch Health
        11.2.1 Bausch Health Company Detail
        11.2.2 Bausch Health Business Overview
        11.2.3 Bausch Health Acne Vulgaris Drug Introduction
        11.2.4 Bausch Health Revenue in Acne Vulgaris Drug Business (2017-2022)
        11.2.5 Bausch Health Recent Development
    11.3 Teva
        11.3.1 Teva Company Detail
        11.3.2 Teva Business Overview
        11.3.3 Teva Acne Vulgaris Drug Introduction
        11.3.4 Teva Revenue in Acne Vulgaris Drug Business (2017-2022)
        11.3.5 Teva Recent Development
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Company Detail
        11.4.2 GlaxoSmithKline Business Overview
        11.4.3 GlaxoSmithKline Acne Vulgaris Drug Introduction
        11.4.4 GlaxoSmithKline Revenue in Acne Vulgaris Drug Business (2017-2022)
        11.4.5 GlaxoSmithKline Recent Development
    11.5 Mylan
        11.5.1 Mylan Company Detail
        11.5.2 Mylan Business Overview
        11.5.3 Mylan Acne Vulgaris Drug Introduction
        11.5.4 Mylan Revenue in Acne Vulgaris Drug Business (2017-2022)
        11.5.5 Mylan Recent Development
    11.6 Almirall
        11.6.1 Almirall Company Detail
        11.6.2 Almirall Business Overview
        11.6.3 Almirall Acne Vulgaris Drug Introduction
        11.6.4 Almirall Revenue in Acne Vulgaris Drug Business (2017-2022)
        11.6.5 Almirall Recent Development
    11.7 Sun Pharma
        11.7.1 Sun Pharma Company Detail
        11.7.2 Sun Pharma Business Overview
        11.7.3 Sun Pharma Acne Vulgaris Drug Introduction
        11.7.4 Sun Pharma Revenue in Acne Vulgaris Drug Business (2017-2022)
        11.7.5 Sun Pharma Recent Development
    11.8 Mayne Pharma
        11.8.1 Mayne Pharma Company Detail
        11.8.2 Mayne Pharma Business Overview
        11.8.3 Mayne Pharma Acne Vulgaris Drug Introduction
        11.8.4 Mayne Pharma Revenue in Acne Vulgaris Drug Business (2017-2022)
        11.8.5 Mayne Pharma Recent Development
    11.9 Lion
        11.9.1 Lion Company Detail
        11.9.2 Lion Business Overview
        11.9.3 Lion Acne Vulgaris Drug Introduction
        11.9.4 Lion Revenue in Acne Vulgaris Drug Business (2017-2022)
        11.9.5 Lion Recent Development
    11.10 HUAPONT
        11.10.1 HUAPONT Company Detail
        11.10.2 HUAPONT Business Overview
        11.10.3 HUAPONT Acne Vulgaris Drug Introduction
        11.10.4 HUAPONT Revenue in Acne Vulgaris Drug Business (2017-2022)
        11.10.5 HUAPONT Recent Development
    11.11 Sine Pharma
        11.11.1 Sine Pharma Company Detail
        11.11.2 Sine Pharma Business Overview
        11.11.3 Sine Pharma Acne Vulgaris Drug Introduction
        11.11.4 Sine Pharma Revenue in Acne Vulgaris Drug Business (2017-2022)
        11.11.5 Sine Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
                  
              

                

                 
List of Tables
    Table 1. Global Acne Vulgaris Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of OTC
    Table 3. Key Players of Prescription Medicine
    Table 4. Global Acne Vulgaris Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Acne Vulgaris Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Acne Vulgaris Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Acne Vulgaris Drug Market Share by Region (2017-2022)
    Table 8. Global Acne Vulgaris Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Acne Vulgaris Drug Market Share by Region (2023-2028)
    Table 10. Acne Vulgaris Drug Market Trends
    Table 11. Acne Vulgaris Drug Market Drivers
    Table 12. Acne Vulgaris Drug Market Challenges
    Table 13. Acne Vulgaris Drug Market Restraints
    Table 14. Global Acne Vulgaris Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Acne Vulgaris Drug Market Share by Players (2017-2022)
    Table 16. Global Top Acne Vulgaris Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris Drug as of 2021)
    Table 17. Ranking of Global Top Acne Vulgaris Drug Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Acne Vulgaris Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Acne Vulgaris Drug Product Solution and Service
    Table 21. Date of Enter into Acne Vulgaris Drug Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Acne Vulgaris Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Acne Vulgaris Drug Revenue Market Share by Type (2017-2022)
    Table 25. Global Acne Vulgaris Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Acne Vulgaris Drug Revenue Market Share by Type (2023-2028)
    Table 27. Global Acne Vulgaris Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Acne Vulgaris Drug Revenue Market Share by Application (2017-2022)
    Table 29. Global Acne Vulgaris Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Acne Vulgaris Drug Revenue Market Share by Application (2023-2028)
    Table 31. North America Acne Vulgaris Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Acne Vulgaris Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Acne Vulgaris Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Acne Vulgaris Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Acne Vulgaris Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Acne Vulgaris Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Acne Vulgaris Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Acne Vulgaris Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Acne Vulgaris Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Acne Vulgaris Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Galderma Company Detail
    Table 42. Galderma Business Overview
    Table 43. Galderma Acne Vulgaris Drug Product
    Table 44. Galderma Revenue in Acne Vulgaris Drug Business (2017-2022) & (US$ Million)
    Table 45. Galderma Recent Development
    Table 46. Bausch Health Company Detail
    Table 47. Bausch Health Business Overview
    Table 48. Bausch Health Acne Vulgaris Drug Product
    Table 49. Bausch Health Revenue in Acne Vulgaris Drug Business (2017-2022) & (US$ Million)
    Table 50. Bausch Health Recent Development
    Table 51. Teva Company Detail
    Table 52. Teva Business Overview
    Table 53. Teva Acne Vulgaris Drug Product
    Table 54. Teva Revenue in Acne Vulgaris Drug Business (2017-2022) & (US$ Million)
    Table 55. Teva Recent Development
    Table 56. GlaxoSmithKline Company Detail
    Table 57. GlaxoSmithKline Business Overview
    Table 58. GlaxoSmithKline Acne Vulgaris Drug Product
    Table 59. GlaxoSmithKline Revenue in Acne Vulgaris Drug Business (2017-2022) & (US$ Million)
    Table 60. GlaxoSmithKline Recent Development
    Table 61. Mylan Company Detail
    Table 62. Mylan Business Overview
    Table 63. Mylan Acne Vulgaris Drug Product
    Table 64. Mylan Revenue in Acne Vulgaris Drug Business (2017-2022) & (US$ Million)
    Table 65. Mylan Recent Development
    Table 66. Almirall Company Detail
    Table 67. Almirall Business Overview
    Table 68. Almirall Acne Vulgaris Drug Product
    Table 69. Almirall Revenue in Acne Vulgaris Drug Business (2017-2022) & (US$ Million)
    Table 70. Almirall Recent Development
    Table 71. Sun Pharma Company Detail
    Table 72. Sun Pharma Business Overview
    Table 73. Sun Pharma Acne Vulgaris Drug Product
    Table 74. Sun Pharma Revenue in Acne Vulgaris Drug Business (2017-2022) & (US$ Million)
    Table 75. Sun Pharma Recent Development
    Table 76. Mayne Pharma Company Detail
    Table 77. Mayne Pharma Business Overview
    Table 78. Mayne Pharma Acne Vulgaris Drug Product
    Table 79. Mayne Pharma Revenue in Acne Vulgaris Drug Business (2017-2022) & (US$ Million)
    Table 80. Mayne Pharma Recent Development
    Table 81. Lion Company Detail
    Table 82. Lion Business Overview
    Table 83. Lion Acne Vulgaris Drug Product
    Table 84. Lion Revenue in Acne Vulgaris Drug Business (2017-2022) & (US$ Million)
    Table 85. Lion Recent Development
    Table 86. HUAPONT Company Detail
    Table 87. HUAPONT Business Overview
    Table 88. HUAPONT Acne Vulgaris Drug Product
    Table 89. HUAPONT Revenue in Acne Vulgaris Drug Business (2017-2022) & (US$ Million)
    Table 90. HUAPONT Recent Development
    Table 91. Sine Pharma Company Detail
    Table 92. Sine Pharma Business Overview
    Table 93. Sine Pharma Acne Vulgaris DrugProduct
    Table 94. Sine Pharma Revenue in Acne Vulgaris Drug Business (2017-2022) & (US$ Million)
    Table 95. Sine Pharma Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Acne Vulgaris Drug Market Share by Type: 2021 VS 2028
    Figure 2. OTC Features
    Figure 3. Prescription Medicine Features
    Figure 4. Global Acne Vulgaris Drug Market Share by Application in 2021 & 2028
    Figure 5. Topical Case Studies
    Figure 6. Oral Case Studies
    Figure 7. Acne Vulgaris Drug Report Years Considered
    Figure 8. Global Acne Vulgaris Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Acne Vulgaris Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Acne Vulgaris Drug Market Share by Region: 2021 VS 2028
    Figure 11. Global Acne Vulgaris Drug Market Share by Players in 2021
    Figure 12. Global Top Acne Vulgaris Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris Drug as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Acne Vulgaris Drug Revenue in 2021
    Figure 14. North America Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 15. North America Acne Vulgaris Drug Market Share by Country (2017-2028)
    Figure 16. United States Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. Canada Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Europe Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Acne Vulgaris Drug Market Share by Country (2017-2028)
    Figure 20. Germany Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. France Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. U.K. Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Italy Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Russia Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Nordic Countries Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Acne Vulgaris Drug Market Share by Region (2017-2028)
    Figure 28. China Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Japan Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. South Korea Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Southeast Asia Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. India Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Australia Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Latin America Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Acne Vulgaris Drug Market Share by Country (2017-2028)
    Figure 36. Mexico Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Brazil Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Middle East & Africa Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Acne Vulgaris Drug Market Share by Country (2017-2028)
    Figure 40. Turkey Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Saudi Arabia Acne Vulgaris Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Galderma Revenue Growth Rate in Acne Vulgaris Drug Business (2017-2022)
    Figure 43. Bausch Health Revenue Growth Rate in Acne Vulgaris Drug Business (2017-2022)
    Figure 44. Teva Revenue Growth Rate in Acne Vulgaris Drug Business (2017-2022)
    Figure 45. GlaxoSmithKline Revenue Growth Rate in Acne Vulgaris Drug Business (2017-2022)
    Figure 46. Mylan Revenue Growth Rate in Acne Vulgaris Drug Business (2017-2022)
    Figure 47. Almirall Revenue Growth Rate in Acne Vulgaris Drug Business (2017-2022)
    Figure 48. Sun Pharma Revenue Growth Rate in Acne Vulgaris Drug Business (2017-2022)
    Figure 49. Mayne Pharma Revenue Growth Rate in Acne Vulgaris Drug Business (2017-2022)
    Figure 50. Lion Revenue Growth Rate in Acne Vulgaris Drug Business (2017-2022)
    Figure 51. HUAPONT Revenue Growth Rate in Acne Vulgaris Drug Business (2017-2022)
    Figure 52. Sine Pharma Revenue Growth Rate in Acne Vulgaris Drug Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed